Clinical Trials

Coastal Carolina Health Care, P.A. (CCHC) is participating in an observational study for Myasthenia Gravis at our New Bern Internal Medicine Specialists office.

You may qualify for this study if you:

• Clinically diagnosed with myasthenia gravis
• Eligible for treatment with vyvgart(efgartigimod) per product label and confirmed with serological testing during study screening period

A member of our research team can provide more detail.

Qualified participants will receive all study-related care and study medication at no cost.  Financial compensation may be provided for time and travel expenses.